SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-000338
Filing Date
2021-01-04
Accepted
2021-01-04 08:15:53
Documents
15
Period of Report
2021-01-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d101173d8k.htm   iXBRL 8-K 30812
2 EX-99.1 d101173dex991.htm EX-99.1 11163
6 GRAPHIC g101173g0101011941052.jpg GRAPHIC 2355
7 GRAPHIC g101173g0101011941426.jpg GRAPHIC 4350
  Complete submission text file 0001193125-21-000338.txt   184763

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krys-20210104.xsd EX-101.SCH 3074
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20210104_lab.xml EX-101.LAB 18886
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20210104_pre.xml EX-101.PRE 11862
8 EXTRACTED XBRL INSTANCE DOCUMENT d101173d8k_htm.xml XML 3446
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 21500238
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences